Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
We’ve been one of the first companies in Europe which invested in large-scale facilities for manufacturing of biopharmaceutical medicines. With the growing need for such therapies in the late 1990‘s we started to offer our expertise as a contract manufacturing partner to external customers – ...
We’ve been one of the first companies in Europe which invested in large-scale facilities for manufacturing of biopharmaceutical medicines. With the growing need for such therapies in the late 1990‘s we started to offer our expertise as a contract manufacturing partner to external customers – ...
"Worlds Apart? A Comparison of the New Product Development Strategies of Biopharmaceutical Firms in Europe and the USA," Industry and Innovation 16, 593-612.Xia T,Roper S.Worlds apart?A comparison of the new product development strategies of biopharmaceutical firms in Europe and the USA. ...
Join Pfizer in the Fight Against Cancer Nearly 41% of Americans will receive a cancer diagnosis during their lifetime. By understanding their risks, people can take action to help detect it early, when it's most treatable. We’re working with our partners at the American Cancer Society to ...
卫康(美国)生物医药有限公司/Vital-One (USA) Biopharmaceutical Company Limited(公司编号: 2261734) 卫康(美国)生物医药有限公司是一家香港公司,注册于观塘,坐落于开源道上,该司已经解散。您可在線浏览卫康(美国)生物医药有限公司的英文名称、中文名称、历史名称、注册编号、成立日期、改名日期、董事等企业信息,并可...
Emerging Markets: Major healthcare infrastructure and increasing healthcare spending in emerging economies provide major growth opportunities for biopharmaceutical companies. Advanced Technologies: Adoption of advanced technologies like CRISPR, AI, and machin...
It is most critical that companies understand what defines compliance for their type of biopharmaceutical product. “We expect the first part of the 21st century to usher in a new golden age of pharmaceuticals. It will begin with the intrududion of a powerful arsenal of weapons against the ...
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
In the biopharma context, the vast majority of the over 600 public and 8000 private companies worldwide have no revenues or earnings, which means that their investment is funded through grants, public or private equity, and/or through resource partnerships with larger, better capitalized public ...